Amethyst Saldia

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Subsequent Malignancies After CD19-Targeted Chimeric Antigen Receptor T Cells in Patients With Lymphoma”.

Subsequent Malignancies After CD19-Targeted Chimeric Antigen Receptor T Cells in Patients With Lymphoma

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.06.027

N/A

0DataRank · unranked

13 citations

Roni Shouval, Jessica Flynn, Sean M. Devlin, Amethyst Saldia, Alejandro Luna +16 more

Shift from Widespread to Tailored Antifungal Prophylaxis in Lymphoma Patients Treated with CD19 CAR T Cell Therapy: Results from a Large Retrospective Cohort

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.10.010

N/A

0DataRank · unranked

12 citations

Alejandro Luna, Gunjan L. Shah, Sean M. Devlin, Magdalena Corona, Joshua Fein +13 more

Outcomes of Terminal Complement Blockade in Adults with High-Risk Transplant-Associated Thrombotic Microangiopathy: A Comparative Analysis

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.11.037

N/A

0DataRank · unranked

0 citations

Glenn Heller, Christina Cho, Joshua Fein, Parastoo B. Dahi, Gunjan L. Shah +14 more